Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication-Reference-Cited by-同舟云学术

Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

Published:2017-05-15 Issue:27 Volume:8 Page:44266-44280
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bilger Andrea¹,Plowshay Julie²³,Ma Shidong¹⁴,Nawandar Dhananjay⁵⁶,Barlow Elizabeth A.¹,Romero-Masters James C.⁷,Bristol Jillian A.¹,Li Zhe⁸,Tsai Ming-Han⁸,Delecluse Henri-Jacques⁸,Kenney Shannon C.¹²

Affiliation:

1. Department of Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA

2. Department of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA

3. Rocky Mountain Infectious Disease Specialists, Aurora, Colorado, USA

4. Sanofi Pharmaceuticals, Cambridge, Massachusetts, USA

5. Department Cellular and Molecular Biology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, USA

6. Department of Cancer Biology and Immunology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA

7. Department of Cellular and Molecular Pathology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, USA

8. Joint DKFZ Inserm Unit U1074, German Cancer Center (DKFZ), Heidelberg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive cancer and spontaneous regression two weeks after papillomavirus infection;2024-09-07

2. Medicinal chemistry strategies toward broad-spectrum antiviral agents to prevent next pandemics;European Journal of Medicinal Chemistry;2024-05

3. How to and should we target EBV in MS?;Expert Review of Clinical Immunology;2024-03-15

4. A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosis;Multiple Sclerosis Journal;2023-12-22

5. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response;Frontiers in Immunology;2023-09-29